SPRY, The start of multi day / week breakout has commenced.SPRY has gained +77.88% last trading day due to FDA conveying benefits of their epinephrine nasal spray -- and a possible commercial approval on a scheduled date.
Investors confidence were UP reflecting the massive price surge last May 11.
Volume has exponentially increased 10 folds from an average of 6.36M to 57.68M.
On the weekly chart, histogram has created higher lows and a break of a longstanding weekly downtrend line. Huge move.
Net buyers are positioning significantly on the stock for further upside valuation of the company.
Expect a series of price growth from here on.
SPOTTED AT 8.0
TAYOR
safeguard capital always.
